Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer

Go back to Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
(NASDAQ: STOK) Delayed: 32.97 +0.01 (0.03%)
Previous Close $32.96    52 Week High
Open $32.94    52 Week Low
Day High $33.56    P/E N/A 
Day Low $32.05    EPS
Volume 977,943